Skip to content
10-Q

Quarterly Report

Ambrx Biopharma, Inc.

0000950170-23-062916

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 7, 2023 63.15M sh
Shares Diluted Q3 2023 · Sep 30, 2023 62.25M sh
Shares Diluted Q3 2023 · Sep 30, 2023 54.44M sh
Shares Diluted Q3 2023 · Sep 30, 2022 38.62M sh
Shares Diluted Q3 2023 · Sep 30, 2022 38.6M sh
Capex Q3 2023 · Sep 30, 2023 $1.08M
Capex Q3 2023 · Sep 30, 2022 $1.01M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$44.99M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$55.97M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $225.26M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $55.61M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $51.08M
Stockholders Equity Q3 2023 · Sep 30, 2023 $242.4M
Stockholders Equity Q3 2023 · Jun 30, 2023 $250.38M
Stockholders Equity Q3 2023 · Dec 31, 2022 $117.85M
Stockholders Equity Q3 2023 · Sep 30, 2022 $127.5M
Stockholders Equity Q3 2023 · Jun 30, 2022 $141.89M
Stockholders Equity Q3 2023 · Dec 31, 2021 $189.97M
Current Liabilities Q3 2023 · Sep 30, 2023 $18.27M
Current Liabilities Q3 2023 · Dec 31, 2022 $16.66M
Total Liabilities Q3 2023 · Sep 30, 2023 $29.1M
Total Liabilities Q3 2023 · Dec 31, 2022 $29.13M
Current Assets Q3 2023 · Sep 30, 2023 $233.82M
Current Assets Q3 2023 · Dec 31, 2022 $90.58M
Total Assets Q3 2023 · Sep 30, 2023 $271.5M
Total Assets Q3 2023 · Dec 31, 2022 $146.98M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.37
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.03
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.40
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.74
Eps Basic Q3 2023 · Sep 30, 2023 −$0.37
Eps Basic Q3 2023 · Sep 30, 2023 −$1.03
Eps Basic Q3 2023 · Sep 30, 2022 −$0.40
Eps Basic Q3 2023 · Sep 30, 2022 −$1.74
Sga Expense Q3 2023 · Sep 30, 2023 $9.41M
Sga Expense Q3 2023 · Sep 30, 2023 $21.62M
Sga Expense Q3 2023 · Sep 30, 2022 $5.1M
Sga Expense Q3 2023 · Sep 30, 2022 $14.49M
Rd Expense Q3 2023 · Sep 30, 2023 $16.27M
Rd Expense Q3 2023 · Sep 30, 2023 $40.41M
Rd Expense Q3 2023 · Sep 30, 2022 $12.44M
Rd Expense Q3 2023 · Sep 30, 2022 $45.21M
Net Income Q3 2023 · Sep 30, 2023 −$22.99M
Net Income Q3 2023 · Sep 30, 2023 −$56.12M
Net Income Q3 2023 · Sep 30, 2022 −$15.57M
Net Income Q3 2023 · Sep 30, 2022 −$67.06M
Operating Income Q3 2023 · Sep 30, 2023 −$25.63M
Operating Income Q3 2023 · Sep 30, 2023 −$60.83M
Operating Income Q3 2023 · Sep 30, 2022 −$15.94M
Operating Income Q3 2023 · Sep 30, 2022 −$64.85M
Revenue Q3 2023 · Sep 30, 2023 $53K
Revenue Q3 2023 · Sep 30, 2023 $1.2M
Revenue Q3 2023 · Sep 30, 2022 $1.6M
Revenue Q3 2023 · Sep 30, 2022 $4.51M